Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo

Title
Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 25, Issue 1, Pages 99-109
Publisher
Bioscientifica
Online
2017-12-22
DOI
10.1530/erc-17-0182

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More